The Management of Atherosclerotic Renovascular Disease

Abstract

Atherosclerotic renovascular disease (ARVD) seems to be a common clinical condition. ARVD is clinically presented as: ‘silent’ renal artery stenosis, renovascular hypertension, ischemic nephropathy leading to deterioration of renal function and recurrent ‘flash’ pulmonary edema. Management of ARVD involves both revascularization and medical treatment. However, the impact of revascularization on kidney function and blood pressure control is a matter of great controversy in view of the results of recent randomized clinical trials. At present, concerted medical management (includes lifestyle modifications, such as smoking cessation) remains the main treatment option for patients with ARVD. However, there is a need to accurately identify individuals who may benefit from renal revascularization.

Quantitative Anatomy of the Intrainganic Arterial Kidney

“…Diagnosis and treatment of renal pathology remains an urgent medical problem [9,10,15,[17][18][19]. Severity of these diseases and their high frequency require new diagnosis and treatment methods, and morphological studies [6,11].…”

“…Information on its main links is controversial. Digital methods of intravital visualization of the intraorgan arterial bed of the kidney open up new opportunities for early diagnostics of kidney pathologies [3,[14][15][16][17][18][19][20][21].…”